Filing Details
- Accession Number:
- 0001127602-19-017302
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-03 17:18:00
- Reporting Period:
- 2019-05-01
- Accepted Time:
- 2019-05-03 17:18:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1252004 | S Robert Epstein | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-01 | 5,000 | $51.17 | 8,256 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-01 | 1,200 | $309.51 | 7,056 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-01 | 2,228 | $310.29 | 4,828 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-01 | 1,372 | $311.23 | 3,456 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-01 | 200 | $312.17 | 3,256 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2019-05-01 | 5,000 | $0.00 | 5,000 | $51.17 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-11-26 | 2022-11-26 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 1,200 shares sold ranging from $308.91 to $309.88 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 2,228 shares sold ranging from $309.94 to $310.9025 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,372 shares sold ranging from $310.95 to $311.81 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $312.11 to $312.22 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
